Cite
Combining genomics and ultra-sensitive bone marrow assessment for risk stratification in high-risk metastatic neuroblastoma: a HR-NBL1/SIOPEN study
MLA
Stefan Fiedler, et al. Combining Genomics and Ultra-Sensitive Bone Marrow Assessment for Risk Stratification in High-Risk Metastatic Neuroblastoma: A HR-NBL1/SIOPEN Study. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..1e3359d0e556c4c1e3b2e3f8ab860eb5&authtype=sso&custid=ns315887. Accessed 5 Mar. 2025.
APA
Stefan Fiedler, Ambros, I. M., Sabine Taschner-Mandl, Ulrike Pötschger, Tommy Martinsson, Ales Vicha, Marta Jeison, Jan Koster, Rosa Noguera, Shifra Ash, Alberto Garaventa, Chan, G. C. F., Walentyna Balwierz, Marek Ussowicz, Tweddle, D. A., Gudrun Schleiermacher, Tytgat, G. A. M., Georg Mann, Martin Benesh, … Ambros. (n.d.). Combining genomics and ultra-sensitive bone marrow assessment for risk stratification in high-risk metastatic neuroblastoma: a HR-NBL1/SIOPEN study.
Chicago
Stefan Fiedler, Inge M. Ambros, Sabine Taschner-Mandl, Ulrike Pötschger, Tommy Martinsson, Ales Vicha, Marta Jeison, et al. 2025. “Combining Genomics and Ultra-Sensitive Bone Marrow Assessment for Risk Stratification in High-Risk Metastatic Neuroblastoma: A HR-NBL1/SIOPEN Study.” Accessed March 5. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..1e3359d0e556c4c1e3b2e3f8ab860eb5&authtype=sso&custid=ns315887.